Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Hospitals

 

What Eko Health’s AI stethoscope can teach us about AI adoption in healthcare

An AI-powered digital stethoscope developed by a California-based medtech company called Eko Health has been found to detect heart conditions with significantly greater sensitivity than doctors using analogue stethoscopes in a trial with 200 UK GP practices. But the same study also found that 70% of these GP surgeries had stopped using them or were only using them infrequently a year after they were given them. In a conversation with HBI, Alfred Olivares and Nick Kovacev, who work for US technology consultancy HTEC, suggested some of the reasons for this, and the broader lessons for health tech companies trying to develop impactful AI tools.

Revenue distribution of top 100 hospital groups in EMEA by country

This week’s infographic aggregates the 2024 total revenues of the top 100 hospital groups across Europe, the Middle East, and Africa, segmented by country, exposing distinct concentrations of market size and investment intensity.  The data has been sourced from the HBI Intelligence database. Germany commands a dominant position with €22.6 billion in hospital revenues, over […]

FREE BLOG Previewing the 2025 Top 100 rankings 

I’m thrilled to give advance notice that HBI’s fifth annual Top 100 ranking will be published next week. Each year our Top 100 ranking has grown in popularity and is now by some distance the most widely read content we publish.

Macquarie buys 40% stake in Luz Saude

Infrastructure investor Macquarie has bought a 40% stake in Luz Saude, Portugal’s second largest private hospital group by revenue, for a base consideration of €310 million. The deal values Luz Saude at €1.1 billion in terms of enterprise value, a 9.5x multiple of the group’s 2024 EBITDA.

Is the profit motive at odds with impact investing goals in emerging market healthcare?

Last week Bloomberg accused US private equity firm TPG of putting profit before the interest of patients in various emerging market hospitals it has invested in. We spoke to TPG to get their response to the specific accusations made against them. We also spoke to others operating in Africa about whether there is, at a more general level, a tension between seeking profit whilst simultaneously seeking to achieve impact investing goals in emerging market healthcare. 

Microsoft launches its AI scribe in the UK

Microsoft is releasing its AI scribe for clinicians, Dragon Copilot, in the UK on Thursday September 4. In a demo with HBI, Dr Simon Wallace, Chief Clinical Information Officer at Microsoft, explained why he believes the product has an edge over the numerous competitors in this space and a good shot at becoming the dominant supplier to the NHS.

Tensions between Indian providers and insurers “likely to continue” in the near term

Long-standing tensions between private Indian healthcare providers and insurers erupted into a major stand-off over the past two weeks. Many North Indian providers unilaterally decided to suspend cashless treatment for people insured by Bajaj Allianz, one of India’s biggest health insurers, because of complaints that claims were not being settled on time. This dispute has now been resolved, but we hear such tensions between providers and payors are a widespread issue in the Indian market and likely to continue in the near term.

Portugal’s competition authority is concerned private healthcare consolidation may have caused price increases

The recently opened investigation into the merger of two of Portugal's biggest private hospital groups — CUF and HPA — by the competition watchdog (AdC) has highlighted concerns about a possible causal connection between price increases seen in the sector and the sector’s trend towards consolidation. AdC tells us, however, that the evidence uncovered so far has only been correlational.

Find Us